CANNABIS USE DISORDER
Clinical trials for CANNABIS USE DISORDER explained in plain language.
Never miss a new study
Get alerted when new CANNABIS USE DISORDER trials appear
Sign up with your email to follow new studies for CANNABIS USE DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a diabetes drug curb cannabis cravings?
Disease control Not yet recruitingThis study tests if semaglutide, a medicine used for diabetes and weight loss, can help adults with cannabis use disorder reduce their cannabis use. About 100 people who want to cut down or stop using cannabis will get either semaglutide or a placebo for 20 weeks. The main goal i…
Matched conditions: CANNABIS USE DISORDER
Phase: PHASE2 • Sponsor: Anders Fink-Jensen, MD, DMSci • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
New therapy aims to cut cannabis use in psychosis patients
Disease control Not yet recruitingThis study tests a therapy program called the Cannabis Clinic for Psychosis (CCP) to help people with first-episode psychosis reduce or stop using cannabis. About 80 adults who are dependent on cannabis and want to cut back will either receive the 12-session CCP therapy right awa…
Matched conditions: CANNABIS USE DISORDER
Phase: NA • Sponsor: King's College London • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
Could a diabetes shot curb cannabis cravings? new trial aims to find out.
Disease control Not yet recruitingThis study tests whether tirzepatide, a drug used for diabetes, can help people with moderate to severe cannabis use disorder use less cannabis. About 100 adults will receive either the drug or a placebo, and researchers will track how many days they stay cannabis-free and any si…
Matched conditions: CANNABIS USE DISORDER
Phase: PHASE2 • Sponsor: National Institute on Drug Abuse (NIDA) • Aim: Disease control
Last updated May 08, 2026 12:02 UTC
-
Weight-Loss drug tested to fight marijuana cravings
Disease control Not yet recruitingThis is a small, early-stage study to see if tirzepatide, a medication currently used for diabetes and weight loss, can help people with severe cannabis addiction. Six participants will receive either the drug or a placebo injection in a random order to test its effects. The main…
Matched conditions: CANNABIS USE DISORDER
Phase: PHASE2 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Apr 16, 2026 13:02 UTC
-
Brain training may ease addiction cravings, new study hopes to prove
Symptom relief Not yet recruitingThis pilot study tests whether a behavioral method called Emotional Brain Training (EBT) can help people in recovery from addiction better manage stress, anxiety, and cravings. About 54 adults receiving standard addiction treatment will either continue their usual care or also at…
Matched conditions: CANNABIS USE DISORDER
Phase: NA • Sponsor: Loma Linda University • Aim: Symptom relief
Last updated May 14, 2026 12:04 UTC